Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Nuclear Medicine

Free Subscription 06.10.2025 2 AJNR Am J Neuroradiol 4 Ann Nucl Med 1 Brain 3 Clin Nucl Med 1 Curr Opin Cardiol 1 IEEE Trans Med Imaging 2 J Nucl Cardiol 10 J Nucl Med 1 Lancet 1 Nucl Med Commun 5 Nuklearmedizin 2 Phys Med Biol 1 PLoS One 2 Semin Nucl Med

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJNR Am J Neuroradiol

1. ZHANG S, Lu W, Yao C, Wang J, et al
   (18)F-FDG PET/MR-Based Individual Metabolic Network Analysis for Prognosis Assessment in Temporal and Extratemporal Lobe Refractory Epilepsy.
   AJNR Am J Neuroradiol. 2025 Sep 30:ajnr.A9027. doi: 10.3174/ajnr.A9027.
   PubMed         Abstract available
   
   
2. MIDDLEBROOKS EH, Lin C, Pooley RA, Spangler-Bickell MG, et al
   Feasibility of MR-Guided PET Reconstruction in Detection of Focal Cortical Dysplasia.
   AJNR Am J Neuroradiol. 2025 Sep 27:ajnr.A9023. doi: 10.3174/ajnr.A9023.
   PubMed         Abstract available
   
   

   
   Ann Nucl Med

3. JIAMING S, Jiani Y
   Comment on the impact of anti-HER2 therapy on the accuracy of 68 Ga-HER2-affibody PET/CT imaging in metastatic breast cancer.
   Ann Nucl Med. 2025 Oct 3. doi: 10.1007/s12149-025-02111.
   PubMed        
   
   
4. SEBAN RD, Champion L, Buvat I
   Response to "Beyond glucose uptake: rethinking PET/CT and hematologic markers for immune profiling in early breast cancer".
   Ann Nucl Med. 2025 Oct 2. doi: 10.1007/s12149-025-02115.
   PubMed        
   
   
5. WU D, Jiang Q, Shen G, Gao X, et al
   Quantitative analysis of striatal subregional asymmetry on (99m)Tc-TRODAT-1 SPECT and clinical correlations with UPDRS subscales in Parkinson's disease.
   Ann Nucl Med. 2025 Oct 1. doi: 10.1007/s12149-025-02112.
   PubMed         Abstract available
   
   
6. ALTUNDAG K
   Beyond glucose uptake: rethinking PET/CT and hematologic markers for immune profiling in early breast cancer.
   Ann Nucl Med. 2025 Sep 30. doi: 10.1007/s12149-025-02114.
   PubMed        
   
   

   
   Brain

7. ANAND C, Abdelnour F, Sipes B, Ma D, et al
   Selective vulnerability and resilience to Alzheimer's disease tauopathy as a function of genes and the connectome.
   Brain. 2025 Jul 9:awaf179. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Clin Nucl Med

8. KIM DW, Park SA, Kim MH
   18 F-PSMA-1007 and 18 F-FDG PET/CT Findings of Pulmonary Tuberculosis Mimicking Malignancy.
   Clin Nucl Med. 2025 Sep 26. doi: 10.1097/RLU.0000000000006137.
   PubMed         Abstract available
   
   
9. PUROHIT P, Preet K, Mittal BR, Kumar R, et al
   Rare Presentation of Lymphomatoid Granulomatosis With CNS, Pulmonary, and Musculoskeletal System Involvement on 18F-FDG PET/CT.
   Clin Nucl Med. 2025 Sep 26. doi: 10.1097/RLU.0000000000005944.
   PubMed         Abstract available
   
   
10. DAMIAN A, Kramer V, Servente L, Ferrando R, et al
    Benign Bone Lesion With Incidental 18F-PR04.MZ Uptake on PET/CT in a Patient With Parkinson's Disease.
    Clin Nucl Med. 2025 Sep 30. doi: 10.1097/RLU.0000000000006093.
    PubMed         Abstract available
    
    

    
    Curr Opin Cardiol

11. KWONG RY, Heydari B, Bernhard B
    A practical review of stress perfusion cardiac magnetic resonance imaging for the management of coronary artery disease.
    Curr Opin Cardiol. 2025;40:448-458.
    PubMed         Abstract available
    
    

    
    IEEE Trans Med Imaging

12. MARQUARDT N, Hengsbach T, Mauritz M, Wirth B, et al
    Motion simulation of radio-labeled cells in whole-body positron emission tomography.
    IEEE Trans Med Imaging. 2025;PP.
    PubMed         Abstract available
    
    

    
    J Nucl Cardiol

13. PASCALE R, Fernandez-Hidalgo N, Tazza B, Bartoletti M, et al
    How to manage patients receiving long-term suppressive antibiotic treatment for infective endocarditis: the role of [18F]-FDG-PET/CT imaging - An international multidisciplinary survey.
    J Nucl Cardiol. 2025 Sep 27:102505. doi: 10.1016/j.nuclcard.2025.102505.
    PubMed        
    
    
14. KHAN MS, Perumalla HS, Modi K, Asif T, et al
    National Trends in Radiopharmaceutical Use for the Diagnosis of Cardiac Amyloidosis from 2019-2024.
    J Nucl Cardiol. 2025 Sep 26:102502. doi: 10.1016/j.nuclcard.2025.102502.
    PubMed        
    
    

    
    J Nucl Med

15. KUJAWSKI M, Aniogo E, Wong P, Hui S, et al
    Combination Image-Guided and Antibody-Targeted alpha-Therapy Before Targeted Immunotherapy for Treatment of Solid Tumors.
    J Nucl Med. 2025;66:1605-1611.
    PubMed         Abstract available
    
    
16. UPRIMNY C, von Guggenberg E, Sviridenko A, Bayerschmidt S, et al
    Diagnostic Performance of the (68)Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Advanced Medullary Thyroid Cancer and Other Neuroendocrine Tumors.
    J Nucl Med. 2025 Aug 28:jnumed.125.269863. doi: 10.2967/jnumed.125.269863.
    PubMed         Abstract available
    
    
17. MURTHY V, Kimura K, Theus L, Nguyen A, et al
    Prognostic Value of AI-Assisted Lesion Tracking on End-of-Treatment PSMA PET in mCRPC Patients Treated with (177)Lu-PSMA: A Retrospective, Single-Center Study.
    J Nucl Med. 2025 Sep 25:jnumed.125.269971. doi: 10.2967/jnumed.125.269971.
    PubMed         Abstract available
    
    
18. DOYON V, Sarrhini O, Loignon-Houle F, Toussaint M, et al
    PET Imaging of the Human Brain with Microvolumetric Spatial Resolution.
    J Nucl Med. 2025 Sep 25:jnumed.124.268809. doi: 10.2967/jnumed.124.268809.
    PubMed         Abstract available
    
    
19. LAZAR A, Matassa G, Hammami DW, Chiti A, et al
    Diagnostic Reliability and Clinical Impact of [(11)C]Choline PET/CT for Detecting Hyperfunctioning Parathyroid Glands.
    J Nucl Med. 2025 Sep 25:jnumed.125.270664. doi: 10.2967/jnumed.125.270664.
    PubMed         Abstract available
    
    
20. CIUCIULKAITE I, Zuccotti GA, Jallo C, Hautzel H, et al
    Thyroid Hormone Withdrawal Yields Higher (131)I Absorbed Dose to Metastases Than rhTSH Stimulation in Differentiated Thyroid Cancer: Evidence from a Large (124)I PET/CT Dosimetry Cohort.
    J Nucl Med. 2025 Sep 25:jnumed.125.270391. doi: 10.2967/jnumed.125.270391.
    PubMed         Abstract available
    
    
21. HOYVIK AJK, Stenberg VY, Liukaityte R, Repetto-Llamazares A, et al
    Optimizing [(212)Pb]Pb-AB001 Radiopharmaceutical Therapy Schedules in PSMA-Positive Subcutaneous Prostate Cancer Xenografts.
    J Nucl Med. 2025 Oct 3:jnumed.125.270444. doi: 10.2967/jnumed.125.270444.
    PubMed         Abstract available
    
    
22. SARTOR O, Emmett L, Herrmann K
    Resisting RECIST: PSMA PET and Regulatory Change in Prostate Cancer.
    J Nucl Med. 2025 Oct 3:jnumed.125.271144. doi: 10.2967/jnumed.125.271144.
    PubMed        
    
    
23. MOSTAFAPOUR S, van Sluis J, van Snick JH, Noordzij W, et al
    Influence of Ultra-Low-Dose CT on PET Image Quantification and Visual Assessment.
    J Nucl Med. 2025 Oct 3:jnumed.124.269188. doi: 10.2967/jnumed.124.269188.
    PubMed         Abstract available
    
    
24. GOLDSTEIN DS, Holmes C, Ding YS
    Multitracer PET to Assess Cardiac Sympathetic Innervation and Vesicular Storage in Lewy Body Diseases.
    J Nucl Med. 2025 Oct 3:jnumed.125.269840. doi: 10.2967/jnumed.125.269840.
    PubMed         Abstract available
    
    

    
    Lancet

25. FRISONI GB, Hansson O, Nichols E, Garibotto V, et al
    New landscape of the diagnosis of Alzheimer's disease.
    Lancet. 2025;406:1389-1407.
    PubMed         Abstract available
    
    

    
    Nucl Med Commun

26. GUO YH, Tian Y, Huang JW, Liu AJ, et al
    Prognostic value of tumor dissemination feature based on baseline 18F-FDG PET/CT in patients with newly diagnosed multiple myeloma.
    Nucl Med Commun. 2025 Sep 25. doi: 10.1097/MNM.0000000000002059.
    PubMed         Abstract available
    
    

    
    Nuklearmedizin

27. MIKSCH J, Yousefzadeh-Nowshahr E, Hardiansyah D, Glatting G, et al
    First clinical application of silicon-based [(1)(8)F]siPSMA-14 in prostate cancer patients: A proof-of-concept study.
    Nuklearmedizin. 2025;64:285-293.
    PubMed         Abstract available
    
    
28. AMBULKAR KS, Shah R, Lila A, Sharma A, et al
    Outcomes of 68Ga-NODAGA-Exendin-4 PET/CT Guided Surgical Management of Insulinomas in MEN1: A Preliminary Study.
    Nuklearmedizin. 2025;64:301-307.
    PubMed         Abstract available
    
    
29. MANDIC A, Kraljevic I, Skoric Polovina T, Zibar Tomsic K, et al
    Diagnostic Performance of 99 mTc-Sestamibi SPECT/CT and 18F-Choline PET/CT in Locating Hyperfunctioning Parathyroid Glands in Patients with Primary Hyperparathyroidism.
    Nuklearmedizin. 2025;64:308-312.
    PubMed         Abstract available
    
    
30. KALANTARI F, Rendl G, Hecht S, Pirich C, et al
    Atypical local laryngeal cancer recurrence mimicking thyroid uptake on 18F-FDG PET/CT.
    Nuklearmedizin. 2025;64:316-317.
    PubMed        
    
    
31. CHIKASUE T, Kurata S, Edamitsu S, Koganemaru M, et al
    Central Conducting Lymphatic Abnormalities in Noonan Syndrome Identified Using SPECT/CT Lymphoscintigraphy.
    Nuklearmedizin. 2025 Sep 30. doi: 10.1055/a-2695-8007.
    PubMed        
    
    

    
    Phys Med Biol

32. CHU H, Lee S, Cates JW, Heller R, et al
    Silicon-based 3D beta ray radiopharmaceutical trackers: a Monte Carlo computational study.
    Phys Med Biol. 2025 Sep 25. doi: 10.1088/1361-6560.
    PubMed         Abstract available
    
    
33. WANG H, Zou W, Wang J, Li J, et al
    Pseudo PET synthesis from CT based on deep neural networks.
    Phys Med Biol. 2025 Sep 24. doi: 10.1088/1361-6560.
    PubMed         Abstract available
    
    

    
    PLoS One

34. TSUJIMOTO M, Watanabe M, Nogami K, Kawai H, et al
    Optimization of acquisition time and reconstruction parameters for quantitative single-photon emission computed tomography/computed tomography using iodine-123 metaiodobenzylguanidine.
    PLoS One. 2025;20:e0330655.
    PubMed         Abstract available
    
    

    
    Semin Nucl Med

35. KABUNDA J, Ndlovu H, Singh K, Sibiya S, et al
    Nectin-4, Bladder Cancer, and Nuclear Medicine: A Theranostic Frontier.
    Semin Nucl Med. 2025 Sep 26:S0001-2998(25)00118.
    PubMed         Abstract available
    
    
36. THIENTUNYAKIT T, Muangpaisan W, Minoshima S
    Corrigendum to '18F-FDG PET for Dementia Evaluation: Co-pathologies, New Diseases, and Its Roles in The Era of Anti-Amyloid Treatment' [Seminar in Nuclear Medicine volume 55 (2025):526 -537/Article number YSNUC_51208].
    Semin Nucl Med. 2025 Sep 25:S0001-2998(25)00116.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge.